Intrapleural Cryotherapy for Malignant Pleural Mesothelioma

Status Terminated

Clinical Trial Summary

Can neoadjuvant intrapleural cryotherapy be safely performed in patients with malignant pleural mesothelioma and will it trigger substantial systemic and local pro-inflammatory changes, resulting in the induction of anti-tumor immunity?

Clinical Trial Description

Patients that have been diagnosed, or are suspected of having malignant pleural mesothelioma, a cancer of the pleura, surgery may be considered as an attempt to treat the cancer. As part of the testing needed before surgery, a pleuroscopy or video camera examination of the pleura is necessary to establish the diagnosis and/or to evaluate the extent of the cancer. This study evaluates the effects of cryotherapy (freezing spray) on the ability of a patient's immune system to attack the cancer, as has been reported in other types of cancers. The purpose of this research is to gather information on the safety and effectiveness of cryotherapy in patients with malignant pleural mesothelioma. If successful, this study could provide support for future studies evaluating this new treatment for mesothelioma. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02464904
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Terminated
Phase	N/A
Start date	July 2015
Completion date	February 26, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Terminated	`NCT01624090` - Mithramycin for Lung, Esophagus, and Other Chest Cancers	Phase 2
Active, not recruiting	`NCT04242199` - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors	Phase 1
Recruiting	`NCT05415098` - Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas	Phase 1
Completed	`NCT03652077` - A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies	Phase 1
Recruiting	`NCT06057935` - A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma	Phase 2
Terminated	`NCT02838745` - Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM	Phase 1
Terminated	`NCT02628535` - Safety Study of MGD009 in B7-H3-expressing Tumors	Phase 1
Recruiting	`NCT01912547` - Thromboelastography During Surgery for Malignant Pleural Mesothelioma	Phase 0
Completed	`NCT01521325` - A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers	Phase 1
Recruiting	`NCT00996385` - Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma	Phase 2
Recruiting	`NCT02073500` - Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Completed	`NCT02467426` - Isolated Thoracic Perfusion (ITP-F) for MPM	Phase 2
Completed	`NCT00407459` - Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma	Phase 2
Completed	`NCT00787410` - An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma	Phase 2
Terminated	`NCT01907100` - Nintedanib (BIBF 1120) in Mesothelioma	Phase 2/Phase 3
Completed	`NCT04056026` - A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma	Early Phase 1
Completed	`NCT02903914` - Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors	Phase 1/Phase 2
Terminated	`NCT03319537` - Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma	Phase 1/Phase 2
Terminated	`NCT03685591` - PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors	Phase 1